title: Metabolic syndrome (MetS) in Lebanese patients with schizophrenia receiving atypical antipsychotic drugs.
authors: R
authors: R
authors: Bou Khalil
authors: J
authors: J
authors: Rohayem
authors: N
authors: N
authors: Abou Said
authors: R
authors: R
authors: El Chammay
authors: R
authors: R
authors: Haddad
authors: S
authors: S
authors: Richa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007861:Lebanon / Q000453:epidemiology; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000453:epidemiology; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents